Investigating the discernible and distinct effects of platinumbased chemotherapy regimens for metastatic triplenegative breast cancer on time to progression

Author：                  

Publisher： Spandidos Publications

ISSN： 1792-1074

Source： Oncology Letters, Vol.7, Iss.3, 2014-01, pp. : 866-870

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Platinumbased chemotherapy in triplenegative breast cancer: A metaanalysis

By            

Oncology Letters, Vol. 5, Iss. 3, 2013-01 ,pp. : 983-991

Spandidos Publications

Access to resources Recommend Favorite

Prolonged time to progression with fulvestrant for metastatic breast cancer

By Mello Celso  

Medical Oncology, Vol. 28, Iss. 2, 2011-06 ,pp. : 416-419

Humana Press, Inc

Access to resources Recommend Favorite

Platinum-based therapy for triple-negative breast cancer treatment: A meta-analysis

By            

Molecular and Clinical Oncology, Vol. 3, Iss. 3, 2015-01 ,pp. : 720-724

Science Publishers

Access to resources Recommend Favorite

A phase I multicenter study of antroquinonol in patients with metastatic non-small-cell lung cancer who have received at least two prior systemic treatment regimens, including one platinum-based chemotherapy regimen

By        

Molecular and Clinical Oncology, Vol. 3, Iss. 6, 2015-01 ,pp. : 1375-1380

Science Publishers

Access to resources Recommend Favorite

Effect of neoadjuvant chemotherapy in patients with triple-negative breast cancer: A meta-analysis

By            

Oncology Letters, Vol. 9, Iss. 6, 2015-01 ,pp. : 2825-2832

Spandidos Publications

Access to resources Recommend Favorite